You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 8,148,333

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,148,333

Title:	Stable composition comprising a PTHrP analogue
Abstract:	The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) analogue and methods of using a PTHrP analogue and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients.
Inventor(s):	Dey; Michael J. (Sandbach, GB), Mondoly; Nathalie (Le Chesnay, FR), Rigaud; Benedicte (Oulins, FR), Henderson; Bart (Belmont, MA), Lyttle; C. Richard (Bala Cynwyd, PA)
Assignee:	Radius Health, Inc. (Cambridge, MA) Ipsen Pharma S.A.S. (Boulogne-Billancourt, FR)
Application Number:	12/311,418
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,148,333
Patent Claims:	1. A storage-stable composition suitable for administration to a subject comprising: a) a PTHrP analogue having the sequence [Glu.sup.22,25, Leu.sup.23,28,31, Aib.sup.29, Lys.sup.26,30] hPTHrP(1-34)NH.sub.2(SEQ ID NO.2); and b) an effective amount of a pH buffer to maintain the pH in a range of about 4.5 to about 5.6. 2. The storage-stable composition according to claim 1, wherein said pH is about 5.1. 3. The storage stable composition according to claim 1, wherein said pH buffer is selected from the group consisting of acetate, tartrate, phosphate and citrate buffers. 4. The storage-stable composition according to claim 3, wherein said pH buffer is an acetate buffer. 5. The storage-stable composition according to claim 4, wherein said acetate buffer is acetic acid and sodium acetate. 6. The storage-stable composition according to claim 5, wherein said buffer is present in a concentration range of about 1 mM to about 10 mM. 7. The storage stable composition according to claim 6 wherein said buffer is present in a concentration of about 6 mM. 8. The storage-stable composition according to claim 1, further comprising an effective amount of an anti-microbial agent. 9. The storage-stable composition according to claim 8, wherein said anti-microbial agent is phenol. 10. The storage-stable composition according to claim 9, wherein said phenol is present in a concentration from about 0.25 to about 5 mg/mL. 11. The storage-stable composition according to claim 10, wherein said phenol is present in a concentration of about 5 mg/mL. 12. The storage-stable composition according to claim 1, wherein said PTHrP analogue is present in a concentration of about 2 mg/mL. 13. The storage-stable composition according to claim 1, wherein said composition does not contain a chemical stabilizer.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.